A. Graybiel, E. Hirsch, and Y. Agid, The nigrostriatal system in Parkinson's disease, Adv. Neurol, vol.53, pp.17-29, 1990.

M. Carlsson and A. Carlsson, Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease, Trends in Neurosciences, vol.13, issue.7, pp.272-276, 1990.
DOI : 10.1016/0166-2236(90)90108-M

W. Schmidt, M. Bubser, and W. Hauber, Excitatory amino acids and Parkinson's disease, Trends in Neurosciences, vol.13, issue.2, pp.46-47, 1990.
DOI : 10.1016/0166-2236(90)90066-J

N. Jonkers, S. Sarre, G. Ebinger, and Y. Michotte, MK801 suppresses the l-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats, Brain Research, vol.926, issue.1-2, pp.149-155, 2002.
DOI : 10.1016/S0006-8993(01)03147-X

C. Meshul, N. Emre, C. Nakamura, C. Allen, M. Donohue et al., Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion, Neuroscience, vol.88, issue.1, pp.1-16, 1999.
DOI : 10.1016/S0306-4522(98)00189-4

N. Bruet, F. Windels, C. Carcenac, C. Feuerstein, A. Bertrand et al., Neurochemical Mechanisms Induced by High Frequency Stimulation of the Subthalamic Nucleus: Increase of Extracellular Striatal Glutamate and GABA in Normal and Hemiparkinsonian Rats, Journal of Neuropathology & Experimental Neurology, vol.62, issue.12, pp.1228-1240, 2003.
DOI : 10.1093/jnen/62.12.1228

F. Calon, M. Morissette, O. Ghribi, M. Goulet, R. Grondin et al., Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.26, issue.1, pp.127-138, 2002.
DOI : 10.1016/S0278-5846(01)00237-8

C. Chassain, G. Bielicki, J. Donnat, J. Renou, A. Eschalier et al., Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic C NMS study in the rat, Experimental Neurology, vol.191, issue.2, pp.276-284, 2005.
DOI : 10.1016/j.expneurol.2004.09.017

G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 1986.

M. Chritin, C. Feuerstein, and M. Savasta, Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat, Molecular Brain Research, vol.19, issue.4, pp.318-322, 1993.
DOI : 10.1016/0169-328X(93)90132-9

M. Rodriguez, I. Morales, J. Gonzalez-mora, I. Gomez, M. Sabate et al., Different levodopa actions on the extracellular dopamine pools in the rat striatum, Synapse, vol.26, issue.2, pp.61-71, 2007.
DOI : 10.1002/syn.20342

S. Wachtel and E. Abercrombie, l-3,4-Dihydroxyphenylalanine-Induced Dopamine Release in the Striatum of Intact and 6-Hydroxydopamine-Treated Rats: Differential Effects of Monoamine Oxidase A and B Inhibitors, Journal of Neurochemistry, vol.63, issue.1, pp.108-117, 1994.
DOI : 10.1046/j.1471-4159.1994.63010108.x

R. Gruetter and . Automatic, Automatic, localizedin Vivo adjustment of all first-and second-order shim coils, Magnetic Resonance in Medicine, vol.89, issue.6, pp.804-811, 1993.
DOI : 10.1002/mrm.1910290613

I. Tkac, Z. Starcuk, I. Choi, and R. Gruetter, In vivo1H NMR spectroscopy of rat brain at 1 ms echo time, Magnetic Resonance in Medicine, vol.39, issue.4, pp.649-656, 1999.
DOI : 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G

P. Provent, N. Kickler, E. Barbier, A. Bergerot, R. Farion et al., The Ammonium-Induced Increase in Rat Brain Lactate Concentration is Rapid and Reversible and is Compatible with Trafficking and Signaling Roles for Ammonium, Journal of Cerebral Blood Flow & Metabolism, vol.37, issue.11, pp.1830-1840, 2007.
DOI : 10.1073/pnas.89.1.212
URL : https://hal.archives-ouvertes.fr/hal-00141736

S. Fitzpatrick, H. Hetherington, K. Behar, and R. Shulman, Effects of acute hyperammonemia on cerebral amino acid metabolism and pHi in vivo

C. Remy, C. Arus, A. Ziegler, E. Lai, A. Moreno et al., In Vivo, Ex Vivo, and In Vitro One- and Two-Dimensional Nuclear Magnetic Resonance Spectroscopy of an Intracerebral Glioma in Rat Brain: Assignment of Resonances, Journal of Neurochemistry, vol.55, issue.1, pp.166-179, 1994.
DOI : 10.1046/j.1471-4159.1994.62010166.x

V. Govindaraju, K. Young, and A. Maudsley, Proton NMR chemical shifts and coupling constants for brain metabolites, NMR in Biomedicine, vol.18, issue.3, pp.129-153, 2000.
DOI : 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V

C. Clarke and M. Lowry, Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes, European Journal of Neurology, vol.12, issue.6, pp.573-577, 2001.
DOI : 10.1093/brain/120.9.1541

M. Fillenz, In vivo neurochemical monitoring and the study of behaviour, Neuroscience & Biobehavioral Reviews, vol.29, issue.6, pp.949-962, 2005.
DOI : 10.1016/j.neubiorev.2005.02.003

S. Robelet, C. Melon, B. Guillet, P. Salin, K. Goff et al., Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease, European Journal of Neuroscience, vol.14, issue.5, pp.1255-1266, 2004.
DOI : 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D

F. Galeffi, L. Bianchi, J. Bolam, D. Corte, and L. , The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis, Eur. J. Neurosci, vol.18, issue.4, pp.856-868, 2003.

C. Corsi, A. Pinna, M. Gianfriddo, M. A. Morelli, M. Pedata et al., Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats, European Journal of Pharmacology, vol.464, issue.1, pp.33-38, 2003.
DOI : 10.1016/S0014-2999(03)01352-9

C. Clarke and M. Lowry, Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy, European Journal of Neurology, vol.69, issue.6, pp.661-665, 2000.
DOI : 10.1046/j.1468-1331.2000.00111.x

A. Brownell, B. Jenkins, D. Elmaleh, T. Deacon, R. Spealman et al., Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease, Nature Medicine, vol.18, issue.11, pp.1308-1312, 1998.
DOI : 10.1016/0091-3057(93)90340-Y

C. Cruz, M. Aminoff, D. Meyerhoff, S. Graham, and M. Weiner, Proton MR spectroscopic imaging of the striatum in Parkinson's disease, Magnetic Resonance Imaging, vol.15, issue.6, pp.619-624, 1997.
DOI : 10.1016/S0730-725X(97)00079-9

C. Ellis, G. Lemmens, S. Williams, A. Simmons, J. Dawson et al., Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study, Neurology, vol.49, issue.2, pp.438-444, 1997.
DOI : 10.1212/WNL.49.2.438

G. Tedeschi, I. Litvan, S. Bonavita, A. Bertolino, N. Lundbom et al., Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration, Brain, vol.120, issue.9, pp.1541-1552, 1997.
DOI : 10.1093/brain/120.9.1541

J. Hakumäki, M. Ala-korpela, and R. Kauppinen, 1 H nuclear magnetic resonance spectroscopy: noninvasive neurochemistry for basic research and clinical applications, Current topics in Neurochemistry, vol.1, pp.59-85, 1997.

M. Podell, M. Hadjiconstantinou, M. Smith, and N. Neff, Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism, Experimental Neurology, vol.179, issue.2, pp.159-166, 2003.
DOI : 10.1016/S0014-4886(02)00015-8

C. Demougeot, C. Marie, M. Giroud, and A. Beley, N-Acetylaspartate: a literature review of animal research on brain ischaemia, Journal of Neurochemistry, vol.90, issue.4
DOI : 10.1111/j.1471-4159.2004.02583.x
URL : https://hal.archives-ouvertes.fr/hal-00499523